An Interactive Preventive Health Record to Increase Colorectal Cancer Screening

NACompletedINTERVENTIONAL
Enrollment

683

Participants

Timeline

Start Date

March 1, 2013

Primary Completion Date

July 31, 2020

Study Completion Date

August 10, 2020

Conditions
Colorectal Cancer Screening
Interventions
BEHAVIORAL

MyCRCS+Prefs

"Patients who are identified by the IPHR as study participants will see an attractive link. In the Prefs arm, via question prompt lists, patients will first identify their CRCS preference using previously developed elicitation strategies.~Tailoring will be used to increase salience of information, motivation, communication, and action plans. We envision the Prefs+ arm in its entirety will be 5-7 minutes, but will depend on Phase I formative work. If the patient remains non-adherent, they will receive an e-mail reminder generated by the IPHR (specific text and frequency determined in Phase I). The Prefs content is identical to the preference portion of the Prefs+Barriers arm, which will allow us to assess the incremental benefit of addressing preferences only and the incremental benefit of addressing preferences and barriers."

BEHAVIORAL

MyCRCS+Prefs+Barriers

"Patients who are identified by the IPHR as study participants will see an attractive link. In the Prefs+Barriers arm, via question prompt lists, patients will first identify their CRCS preference using previously developed elicitation strategies, and subsequently based on their test preference determine their top 3-5 test-specific barriers/concerns in real time.~Tailoring will be used to increase salience of information, motivation, communication, and action plans. We envision the Prefs+Barriers arm in its entirety will be 15-25 minutes, but will depend on Phase I formative work. If the patient remains non-adherent, they will receive an e-mail reminder generated by the IPHR (specific text and frequency determined in Phase I). The Prefs content is identical to the preference portion of the Prefs+Barriers arm, which will allow us to assess the incremental benefit of addressing preferences only and the incremental benefit of addressing preferences and barriers."

Trial Locations (2)

19122

Temple University - General Internal Medicine, Philadelphia

23298

Virginia Ambulatory Care Outcomes Research Network, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Virginia Commonwealth University

OTHER

lead

Temple University

OTHER

NCT01885351 - An Interactive Preventive Health Record to Increase Colorectal Cancer Screening | Biotech Hunter | Biotech Hunter